Company profile
Day One Biopharmaceuticals
Now part of Servier Group
- Industry
- Biotechnology Research
- Employees
- 242
- Headquarters
- Brisbane, California
- LinkedIn followers
- 38,482
- Office locations
- 1
Day One Biopharmaceuticals company summary
Day One Biopharmaceuticals is a company in the Biotechnology Research industry, headquartered in Brisbane, California. On LinkedIn the company has around 242 employees and 38,482 followers. Its listed specialties include Oncology, Cancer, Drug Development, Biotechnology, Pediatric Oncology.
What technology does Day One Biopharmaceuticals use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Day One Biopharmaceuticals
Day One Biopharmaceuticals is now a part of Servier Group. Day One is a commercial-stage company that believes when it comes to pediatric cancer, we can do better. Day One was founded to address a critical unmet need: the dire lack of therapeutic development in pediatric cancer. Inspired by “The Day One Talk” that physicians have with patients and their families about an initial cancer diagnosis and treatment plan, Day One aims to re-envision cancer drug development and redefine what’s possible for all people living with cancer—regardless of age—starting from Day One. Day One partners with leading clinical oncologists, families, and scientists to identify, acquire, and develop important targeted cancer treatments. The company’s pipeline includes tovorafenib (OJEMDA™), DAY301, and following the recently announced acquisition of Mersana Therapeutics, Emi-Le (emiltatug ledadotin), a novel antibody drug conjugate (ADC) targeting the B7-H4 protein in clinical development to treat the rare cancer adenoid cystic carcinoma (ACC).
Specialties
Where is Day One Biopharmaceuticals located?
Day One Biopharmaceuticals lists 1 location.
Compare companies similar to Day One Biopharmaceuticals
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Day One Biopharmaceuticals dayonebio.com | Biotechnology Research | 242 | - | Brisbane, California |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Day One Biopharmaceuticals
What does Day One Biopharmaceuticals do?
Day One Biopharmaceuticals is now a part of Servier Group. Day One is a commercial-stage company that believes when it comes to pediatric cancer, we can do better. Day One was founded to address a critical unmet need: the dire lack of therapeutic development in pediatric cancer. Inspired by “The Day One Talk” that physicians have with patients and their families about an initial cancer diagnosis and treatment plan, Day One aims to re-envision cancer drug development and redefine what’s possible for all people living with cancer—regardless of age—starting from Day One. Day One partners with leading clinical oncologists, families, and scientists to identify, acquire, and develop important targeted cancer treatments. The company’s pipeline includes tovorafenib (OJEMDA™), DAY301, and following the recently announced acquisition of Mersana Therapeutics, Emi-Le (emiltatug ledadotin), a novel antibody drug conjugate (ADC) targeting the B7-H4 protein in clinical development to treat the rare cancer adenoid cystic carcinoma (ACC).
How many employees does Day One Biopharmaceuticals have?
Day One Biopharmaceuticals has around 242 employees on LinkedIn.
Where is Day One Biopharmaceuticals headquartered?
Day One Biopharmaceuticals is headquartered in Brisbane, California.
Build a lead list from companies like Day One Biopharmaceuticals
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.